Elevated levels of LDH-A are a hallmark of many tumours, including GBM, and correlate to a poor prognosis in several human malignancies16, 17, 18, to the point that altered serum and plasma LDH-A levels have been proposed as a possible biomarker of different types of cancer19, 20. This evidence concerns the gene LDHA and glioblastoma.